Home / Health / Arthritis Drug Recalled: Glass Particles Found
Arthritis Drug Recalled: Glass Particles Found
14 Aug
Summary
- Tyenne injection vials recalled nationwide due to glass particles.
- Glass particles can cause local irritation or life-threatening clots.
- Contact manufacturer or doctor if you have recalled Tyenne vials.
The U.S. Food & Drug Administration (FDA) has announced a nationwide recall of Tyenne injection vials, a medication used to treat moderate to severe rheumatoid arthritis. An internal investigation by the manufacturer revealed the presence of glass particles within the affected vials.
The FDA warns that using a recalled vial can result in local irritation or swelling at the injection site. More serious risks include the formation of life-threatening blood clots in the lungs or permanent organ damage, and even death, due to blocked blood flow.
This recall specifically impacts 400 mg/20 mL Tyenne injection vials, which have been distributed across the country. Healthcare providers and patients possessing these vials are instructed to discontinue their use immediately and return them to the manufacturer. Any individuals who have used a recalled vial and are experiencing health concerns should seek immediate medical attention.
